z-logo
open-access-imgOpen Access
Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice
Author(s) -
Llibre JM,
Martínez E,
Barreiro P,
Escrig R,
Ribera E,
Cervantes M,
Imaz A,
Gutierrez F,
Knobel H,
Ornelas A,
Zamora FX,
Clotet B
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p35
Subject(s) - medicine , raltegravir , salvage therapy , pharmacology , protease , intensive care medicine , virology , viral load , antiretroviral therapy , human immunodeficiency virus (hiv) , chemotherapy , enzyme , biochemistry , chemistry
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here